Read More Pharma Industry News Innovent, Hutchmed announce conditional approval for cancer drug combination therapy Innovent Biologics and Hutchmed (china) limited have received conditional nmpa approval for the combination therapy of tyvyt (sintilimab… byPallavi MadhirajuDecember 4, 2024